Main Article Content
Bacground:Maternal and child health, has always been, is and will continue to be a top and overriding priorityin obstetric practice. Unfortunately, despite the constant improvement and progress of science and knowledge,preeclampsia remains a threatening (often fatal) factor,for both the future mother and the infant.
Aimsof our research are the study of magnesium deficiency: highliting of patients with clinical signs of magnesium deficiency, study of the use effectiveness of magnesium to prevent pre-eclampsia.
MaterialsandMethods:200 pregnant women participated in the study. 100 respondents were at risk of preeclampsia,the degree of magnesium deficiency was established,and correctional therapywas conducted for them. 50 women formed a control group(magnesium preparations were not injected into their destination list). To correct the magnesium content of the bodyoral magnesium drugs were used:magnesium oxide light, magnesium carbonate,microgranulated powder magnesium oxide.
Results: preeclampsia risk analysis showed a 100% magnesium deficiency,76%of women had a significant magnesium deficiency, 24% ‑ moderate. Treatment magnesium oral preparationsinto pregnant women reduced the risk of pregnancy termination and placenta dysfunction; complications of childbirth and caesarean sections.Prevention of preeclampsia was 96.0%.Kids with magnesium-receiving mothers,were above according to the Apgar scale, there was a decrease in the incidence of nervous system damage.
Conclusions: Treatment magnesium for pregnant womenhave demonstrated their safety and effectiveness in preventing preeclampsia; reduce the incidence of post-natal complications in newborns.